COIN: A Pilot Study of Cash Transfers to Improve Outcomes in Low-Income Preterm Neonates and Their Families
NCT ID: NCT05930327
Last Updated: 2024-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2023-07-26
2023-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will measure the feasibility and acceptability of the intervention, birthing parents' lived experiences of having a preterm infant and the impacts of cash transfers, and conduct a preliminary assessment of efficacy on birthing parent psychological stress and ability to invest in their infant's care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Preterm Infant Outcomes With Family Integrated Care and Mobile Technology
NCT03418870
Philadelphia Preterm Prevention Project
NCT01117922
Providing Oxygen During Intubation in the NICU Trial
NCT05451953
Extubation Readiness Study in Very Low Birthweight Infants
NCT01471431
Flow-cycled Ventilation in Preterm Infants
NCT02522455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A growing body of literature suggests that monthly unconditional cash transfers (UCTs) - no strings attached monthly cash payments - to low-income families may be an effective intervention to reduce poverty and financial stress, improve psychological health, and improve child health outcomes. However, current studies on UCTs focus primarily on term infants or heterogenous samples of children, with only a single pilot delivering direct financial assistance to low-income preterm infants. Thus, despite well-documented disparities in outcomes for low-income preterm infants, the impact of UCTs among low-income preterm infants and their families remains unknown.
Toward that end, the investigators are conducting a pilot randomized controlled trial of unconditional cash transfers among Medicaid-eligible birthing parents of preterm infants in a single NICU in Pennsylvania. The investigators have three specific aims:
Aim 1: To determine the feasibility and acceptability of randomizing high-value ($325/month) and low-value ($25/month) UCTs to low-income birthing parents of preterm infants beginning in the first month of life.
Aim 2: To examine birthing parents' lived experiences managing the financial impact of having a preterm infant and the perceived impact.
Exploratory Aim 3: To conduct a preliminary assessment of the efficacy of monthly UCTs on birthing parent psychological stress and ability to invest in their infant's care, recognizing the pilot is not designed to be powered for statistical significance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-Value Cash Transfer
Participants in the treatment group will receive four $325 payments. The first payment will be disbursed at the time of enrollment (between birth and 4 weeks of age), and second payment on the infant's one-month birthday, third payment on the infant's two-month birthday, and the fourth payment on the infant's three-month birthdays.
Unconditional Cash Transfer (High-Value)
Monthly, Unconditional Cash Transfer ($325) for 4-months
Low-Value Cash Transfer
Participants in the control group will receive four $25 payments. The first payment will be disbursed at the time of enrollment (between birth and 4 weeks of age), and second payment on the infant's one-month birthday, third payment on the infant's two-month birthday, and the fourth payment on the infant's three-month birthdays.
Unconditional Cash Transfer (Low-Value)
Monthly, Unconditional Cash Transfer ($25) for 4-months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unconditional Cash Transfer (High-Value)
Monthly, Unconditional Cash Transfer ($325) for 4-months
Unconditional Cash Transfer (Low-Value)
Monthly, Unconditional Cash Transfer ($25) for 4-months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Children's Hospital of Philadelphia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Duncan, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Philadelphia/University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bouchelle ZM, Nelin TD, Salazar EG, Ragland S, Uwawuike D, Radack JK, Duncan AF. Unconditional cash transfers to low-income preterm infants and their families: a pilot randomized controlled trial. J Perinatol. 2025 Sep;45(9):1233-1239. doi: 10.1038/s41372-025-02293-2. Epub 2025 Apr 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
852454
Identifier Type: OTHER
Identifier Source: secondary_id
23-021011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.